We are well into the undesirable 2nd wave of COVID-19 and hospitals are filling up with increasing numbers of patients require hospital services. Clearly, at times like this it is important that Diabetes and Endocrine teams maintain essential In-patient and Outpatient Diabetes and Endocrine services, geared towards supporting patients and avoiding further hospital admissions. The document from SfE is a good guide for the teams to follow.

This is the final ABCD webinar in a series of four.

New education platform focuses on diabetes technology training, data management and remote patient monitoring (RPM)

NICE approve Saxenda injections (GLP-1 therapy) for people with pre-diabetes who have BMI of at least 35 kg/m² and high cardiovascular risk. Further details outlined on NICE website:

https://www.nice.org.uk/news/article/nice-recommends-new-treatment-option-for-adults-with-obesity-and-non-diabetic-hyperglycaemia-who-have-a-high-risk-of-cardiovascular-disease

We provide a range of education to people with diabetes to help them make the best use of diabetes technology.

We offer a range of resources for healthcare professionals, including Academy™ - the educational platform for diabetes technology and a series of educational videos featuring experts in the field.

Coming to your inbox on the 18th November - make sure it doesn't get buried under all the other very important emails!

We are due to launch the annual census of Consultants in Diabetes and Endocrinology. This is being done on behalf of ABCD, SfE, Diabetes UK and The Royal College of Physicians London who are also project managing this census.

There has never been a more important time to gather information about how were all working and the impact our jobs have on our lives.